FDA Adverse Event Injury Summary report: N

TXB TISSUE REMOVAL SYSTEM - MICROTIP

MDR report key: 10405661 · Received August 13, 2020

Report

Report Number
1000135560-2020-00038
Event Type
Injury
Date Received
August 13, 2020
Date of Event
July 6, 2020
Report Date
August 18, 2020
Manufacturer
TENEX HEALTH, INC.
Product Code
LFL
PMA / PMN Number
K181367
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

FOLLOW-UP REPORT #01. FIELDS A1, A2, A4, A5, A6, B3, B4, E1, G4, G7, H1, H2 AND H10 UPDATED. ADDITIONAL INFORMATION ON THE PATIENT AND EVENT WAS PROVIDED. THE PATIENT WAS APPARENTLY STARTED ON ANTIBIOTICS EITHER THE DAY OF, OR THE DAY BEFORE, THE PROCEDURE. FOLLOWING ADMISSION TO THE HOSPITAL, THE PATIENT REQUIRED INCISION AND DRAINAGE OF THE SURGICAL SITE, IV ANTIBIOTICS AND RESECTION OF APPROXIMATE FOOT JOINT. THE PATIENT ALSO EXPERIENCED DELAYED CLOSURE OF THE INCISION.

Description of Event or Problem · 1

A USER REPORTED AN INFECTION IN THE WOUND AREA OF A DIABETIC FOOT ULCER IN A PATIENT TREATED WITH THE TENEX HEALTH TX SYSTEM. IT IS UNCLEAR IF PROPHYLACTIC ANTIBIOTICS WERE USED. A C-ARM (FLUOROSCOPIC IMAGER) WAS APPARENTLY USED DURING THE PROCEDURE, AND POSSIBLY NOT STERILE DRAPED. THE REPORTER FELT THAT BACTERIA WERE LIKELY PRESENT AT THE DFU WOUND BEFORE AND/OR AT TIME OF TREATMENT. TWO PORTALS WERE MADE AROUND THE WOUND FOR TREATMENT WITH THE TXB MICROTIP. THE TREATED AREAS WERE FLUSHED FOR APPROXIMATELY ONE MINUTE FOLLOWING TREATMENT. THE PATIENT HAS BEEN ADMITTED TO THE HOSPITAL FOR FURTHER CARE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
869925 TXB TISSUE REMOVAL SYSTEM - MICROTIP INSTRUMENT, ULTRASONIC SURGICAL LFL TENEX HEALTH, INC. 554-3003-001 19119-02-202106

Patients

Seq Age Sex Outcome Treatment
1 62 YR Other